MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/medicina62010208

Медицинская библиотека · Medicina (Kaunas, Lithuania) · 2026

The Role of DLNO in the Functional Assessment of Patients with Idiopathic Pulmonary Fibrosis.

Tondo Pasquale, Ora Josuel, Natale Matteo Pio, Scioscia Giulia, Zerillo Bartolomeo, Di Maggio Matteo Salvatore, Rogliani Paola, Lacedonia Donato

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

Background and

Objectives

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by alveolar-capillary membrane remodeling and impaired gas diffusion. The diffusing capacity of the lung for nitric oxide (DLNO) has been proposed as a physiological parameter reflecting membrane diffusing capacity and pulmonary vascular involvement, potentially providing complementary information to diffusing capacity of the lung for carbon monoxide (DLCO). This study aimed to evaluate the role of DLNO in the functional assessment of patients with IPF and its correlation with clinical and echocardiographic outcomes. Materials and

Methods

This observational, retrospective study included 35 consecutive IPF patients receiving antifibrotic therapy between February and December 2023. All participants underwent plethysmography, combined single-breath DLNO and DLCO testing, six-minute walk test (6MWT), mMRC dyspnea scale assessment, and echocardiography for the estimation of a higher probability of pulmonary hypertension (PH).

Results

DLNO was significantly lower in males compared to females (49.3 ± 16.7% vs. 74.6 ± 16.1%, p < 0.001), with a reduced DLNO/DLCO ratio in men. DLNO correlated with oxygen therapy requirement (p = 0.010) and lower oxygen saturation during the 6MWT (p = 0.021). Patients with higher echocardiographic probability of PH showed markedly reduced DLNO values (17.6 ± 7.6%, p = 0.016) and higher FVC/DLNO ratios (2.31 ± 0.85 vs. 1.65 ± 0.64, p = 0.023), together with lower DLCO levels (p = 0.037).

Conclusions

DLNO may complement DLCO in the evaluation of gas exchange and alveolar-capillary dysfunction in IPF. Although preliminary, these findings support the potential clinical utility of DLNO as an adjunct parameter in the functional characterization of IPF. Further multicenter studies are warranted to confirm these results.

Для цитирования: Tondo Pasquale, Ora Josuel, Natale Matteo Pio, Scioscia Giulia, Zerillo Bartolomeo, Di Maggio Matteo Salvatore, Rogliani Paola, Lacedonia Donato. The Role of DLNO in the Functional Assessment of Patients with Idiopathic Pulmonary Fibrosis.. Medicina (Kaunas, Lithuania). 2026. DOI: 10.3390/medicina62010208.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.